Archive

Archive for the ‘Quarterlly Achievements’ Category

Aastrom Biosciences (ASTM) Q1/12 Results and Highlights

May 10th, 2012 No comments

    Net loss of $9.7M, or $0.25 per share Read more…

Cytori (CYTX) Q1/12 Results and Highlights

May 9th, 2012 No comments

   Net loss was $9.3M, or $0.16 per share Read more…

Neuralstem (Amex: CUR) Q1/12 results and Highlights

May 9th, 2012 No comments

      Net loss of $2.45M or $0.05 per share Read more…

Dendreon (DNDN) Q1/12 Results and Highlights

May 8th, 2012 No comments

   Net loss was $103.9M or $0.70 per share Read more…

Osiris (OSIR) Q4/11 and FY11 Results

March 9th, 2012 No comments

Net income was $5M or $0.15 per share Read more…

Geron (GERN) FY11 Highlights Clinical Development with Quarterly Earnings

March 8th, 2012 No comments

Geron made the decision to focus exclusively on its oncology programs, Read more…

Updating Cytori Therapeutics (CYTX)

September 27th, 2010 No comments

Maintaining a BUY ranking as the stock appreciates each day – slowly – as market dynamics sputter, but 

Read more…